Teresa Marie Bilhorn is a pharmacist who is specialized in Nuclear in Rochester, New York. Patients can reach her at 110 Science Pkwy Ste 300, Rochester or contact her on 585-442-7030. Active license number of Teresa Marie Bilhorn is 5803563 for Nuclear in New York. Teresa Marie Bilhorn is a licensed pharmacist who has demonstrated specialized knowledge and skill in procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals.
Complete Profile:
Teresa Marie Bilhorn speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Teresa Marie Bilhorn
Specialization:
Nuclear
Credentials:
RPH, BCNP
Gender:
Female
Location:
110 Science Pkwy Ste 300, Rochester, New York, 14620-4251
Phone:
585-442-7030
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Teresa Marie Bilhorn are as mentioned below.
NPI Number:
1316061104
NPI Enumeration Date:
19 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Teresa Marie Bilhorn are as mentioned below.
Specialization
License Number
State
Status
Nuclear
5803563
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
18 Saddle Ridge Trl, Fairport, New York
Zip:
14450-9584
Phone Number:
585-421-9708
Fax Number:
--
Patients can reach Teresa Marie Bilhorn at 110 Science Pkwy Ste 300, Rochester, New York or can call on phone at 585-442-7030.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.